Literature DB >> 36166189

Biliatresone: progress in biliary atresia study.

Jia-Jie Zhu1, Yi-Fan Yang1, Rui Dong1, Shan Zheng2.   

Abstract

BACKGROUND: Biliary atresia (BA) is one of the main causes of neonatal end-stage liver disease. Without timely diagnosis and treatment, most children with BA will develop irreversible liver fibrosis within the first two months. While current theorized causes of BA include viral infection, immune disorders, and genetic defects, the comprehensive etiology is still largely unknown. Recently, biliatresone attracted much interest for its ability to induce BA in both zebrafish and mice, so we summarized the latest progress of biliatresone research in BA and tried to answer the question of whether it could provide further clues to the etiology of human BA. DATA SOURCES: We conducted a PubMed search for any published articles related to the topic using search terms including "biliary atresia", "biliatresone", "GSH", and "HSP90". Relevant data were extracted from the original text or supplementary materials of the corresponding articles.
RESULTS: Biliatresone had shown its unique toxicity in multiple species such as zebrafish and mice, and pathogenic factors involved included glutathione (GSH), heat shock protein 90 (HSP90) and the related pathways. In combination with epidemiological evidence and recent studies on the intestinal flora in biliary atresia, a new pathogenic hypothesis that the occurrence of biliary atresia is partly due to biliatresone or its structure-like compounds depositing in human body via vegetables or/and the altered intestinal flora structure can be tentatively established.
CONCLUSIONS: Based on the existing evidence, we emphasized that GSH and HSP90 are involved in the development of BA, and the maternal diet, especially higher vegetable intake of Asian women of childbearing age, accompanied by the altered intestinal flora structure, may contribute to the occurrence of biliary atresia and the higher incidence in the Asia group. However, the evidence from large sample epidemiological research is necessary.
© 2022. The Author(s).

Entities:  

Keywords:  Biliary atresia; Biliatresone; Glutathione; Gut flora

Year:  2022        PMID: 36166189     DOI: 10.1007/s12519-022-00619-0

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   9.186


  58 in total

1.  Epidemiology of biliary atresia in France: a national study 1986-96.

Authors:  C Chardot; M Carton; N Spire-Bendelac; C Le Pommelet; J L Golmard; B Auvert
Journal:  J Hepatol       Date:  1999-12       Impact factor: 25.083

2.  Regulation of epithelial injury and bile duct obstruction by NLRP3, IL-1R1 in experimental biliary atresia.

Authors:  Li Yang; Tatsuki Mizuochi; Pranavkumar Shivakumar; Reena Mourya; Zhenhua Luo; Sridevi Gutta; Jorge A Bezerra
Journal:  J Hepatol       Date:  2018-06-08       Impact factor: 25.083

3.  Diagnosis of biliary atresia: relative accuracy of percutaneous liver biopsy, open liver biopsy, and operative cholangiography.

Authors:  D M Hays; M M Woolley; W H Snyder; J L Reed GB GWINN; B H Landing
Journal:  J Pediatr       Date:  1967-10       Impact factor: 4.406

Review 4.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

5.  Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts.

Authors:  K L Tyler; R J Sokol; S M Oberhaus; M Le; F M Karrer; M R Narkewicz; R W Tyson; J R Murphy; R Low; W R Brown
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

6.  Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Kathleen M Campbell; Gregg E Sabla; Alexander Miethke; Greg Tiao; Monica M McNeal; Richard L Ward; Jorge A Bezerra
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

7.  Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements.

Authors:  Sanjiv Harpavat; Joseph A Garcia-Prats; Carlos Anaya; Mary L Brandt; Philip J Lupo; Milton J Finegold; Alice Obuobi; Adel A ElHennawy; William S Jarriel; Benjamin L Shneider
Journal:  JAMA       Date:  2020-03-24       Impact factor: 56.272

8.  Universal screening for biliary atresia using an infant stool color card in Taiwan.

Authors:  Cheng-Hui Hsiao; Mei-Hwei Chang; Huey-Ling Chen; Hung-Chang Lee; Tzee-Chung Wu; Chieh-Chung Lin; Yao-Jong Yang; An-Chyi Chen; Mao-Meng Tiao; Beng-Huat Lau; Chia-Hsiang Chu; Ming-Wei Lai
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

Review 9.  Biliary Atresia - emerging diagnostic and therapy opportunities.

Authors:  Urban Lendahl; Vincent C H Lui; Patrick H Y Chung; Paul K H Tam
Journal:  EBioMedicine       Date:  2021-11-12       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.